Production of the world’s only flat-panel cardiac cath system, Innova 2000, will soon double, according to developer GE Medical Systems. The boost in production is due to rising customer demand for the product, according to GE, which reports a
Production of the world’s only flat-panel cardiac cath system, Innova 2000, will soon double, according to developer GE Medical Systems. The boost in production is due to rising customer demand for the product, according to GE, which reports a backlog of more than 200 orders. Innova 2000 uses the Revolution amorphous silicon detector, which converts x-rays into digital signals. The detector is also being adapted to allow dual-energy chest radiography. GE announced in early September that the FDA has cleared this version of the detector for use in dual-energy subtraction studies of the chest. With the newly refined detector, the chest system automatically generates three images: a standard radiograph, an image of the soft tissue with the bones removed, and an image of the skeletal system. This set of images promises to help radiologists detect smaller pathologies and reduce the need for additional scanning procedures.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.